ID

16912

Descripción

ONTAK® in Treating Patients With Advanced Breast Cancer That Did Not Respond to Previous Treatment; ODM derived from: https://clinicaltrials.gov/show/NCT00425672

Link

https://clinicaltrials.gov/show/NCT00425672

Palabras clave

Versiones (1)
  1. 13/8/16 13/8/16 -
Subido en

13 de agosto de 2016

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Male Breast Cancer NCT00425672

Inglés

Eligibility Male Breast Cancer NCT00425672

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients with advanced stage refractory breast cancer
Descripción

Refractory breast cancer

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0678222
UMLS CUI [1,2]
C0205269
progressive or relapsed disease following standard therapy
Descripción

progressive or relapsed disease following standard therapy

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0677932
UMLS CUI [1,2]
C0087111
UMLS CUI [2,1]
C0277556
UMLS CUI [2,2]
C0087111
patients must have measurable disease that can include, but is not limited to bone; specifically, patients must have measurable extraskeletal disease that can be accurately measured in at least one dimension as >= 20 mm with conventional ct techniques or >= 10 mm with spiral ct scan; measurable (bi-dimensional) chest wall disease will also be allowed
Descripción

Measurable disease

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1513041
patients must be at least 14 days out from last cytotoxic chemotherapy; patients on bisphosphonates are eligible
Descripción

Cytotoxic chemotherapy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0677881
white blood cell count (wbc) > 3.0 thou/ul
Descripción

White blood cell count

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0023508
anc > 1.0 thou/ul
Descripción

Neutrophil count

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0200633
platelets >= 100 thou/ul
Descripción

Platelet count

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032181
serum creatinine =< 2.0 mg/dl or creatinine clearance (calculated) >= 60 ml/min
Descripción

Serum creatinine or creatinine clearance

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0201976
UMLS CUI [2]
C2711451
alt/ast =< 2.0 x upper limit of normal
Descripción

ALT/AST

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0201836
UMLS CUI [2]
C0201899
total bilirubin =< 1.5 x upper limit of normal
Descripción

Total bilirubin

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0201913
albumin >= 3.0 g/dl
Descripción

Albumin

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0201838
subjects must have a performance status score (ecog scale) =< 2
Descripción

ECOG

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1520224
subjects must have recovered from major infections and/or surgical procedures and, in the opinion of the investigator, not have a significant active concurrent medical illness precluding protocol treatment
Descripción

Active concurrent medical illness precluding protocol treatment

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0525058
UMLS CUI [1,2]
C0439801
UMLS CUI [1,3]
C0009488
men and women of reproductive ability must agree to contraceptive use during the study and for 1month after ontak treatment is discontinued
Descripción

Contraceptive methods

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0700589
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
prior treatment with ontak (dab389 il-2) or dab486 il-2
Descripción

Prior treatment with ontak (dab389 il-2) or dab486 il-2

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0722264
UMLS CUI [2]
C0063713
known history of hypersensitivity to diphtheria toxin or il-2
Descripción

Hypersensitivity to diphtheria toxin or il-2

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0012550
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0021756
active autoimmune disease
Descripción

Autoimmune disease

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0004364
known history of pulmonary disease except controlled asthma
Descripción

Pulmonary disease

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0024115
history of or pre-existing, cardiovascular disease as defined by new york heart association (nyha) class iii-iv categorization
Descripción

cardiovascular disease as defined by new york heart association class iii-iv categorization

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0007222
UMLS CUI [1,2]
C1275491
pregnant or breast-feeding women
Descripción

Pregnant or breast-feeding

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
Volver a la parte superior de la página

Similar models

Eligibility Male Breast Cancer NCT00425672

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Refractory breast cancer
Item
patients with advanced stage refractory breast cancer
boolean
C0678222 (UMLS CUI [1,1])
C0205269 (UMLS CUI [1,2])
progressive or relapsed disease following standard therapy
Item
progressive or relapsed disease following standard therapy
boolean
C0677932 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
C0277556 (UMLS CUI [2,1])
C0087111 (UMLS CUI [2,2])
Measurable disease
Item
patients must have measurable disease that can include, but is not limited to bone; specifically, patients must have measurable extraskeletal disease that can be accurately measured in at least one dimension as >= 20 mm with conventional ct techniques or >= 10 mm with spiral ct scan; measurable (bi-dimensional) chest wall disease will also be allowed
boolean
C1513041 (UMLS CUI [1])
Cytotoxic chemotherapy
Item
patients must be at least 14 days out from last cytotoxic chemotherapy; patients on bisphosphonates are eligible
boolean
C0677881 (UMLS CUI [1])
White blood cell count
Item
white blood cell count (wbc) > 3.0 thou/ul
boolean
C0023508 (UMLS CUI [1])
Neutrophil count
Item
anc > 1.0 thou/ul
boolean
C0200633 (UMLS CUI [1])
Platelet count
Item
platelets >= 100 thou/ul
boolean
C0032181 (UMLS CUI [1])
Serum creatinine or creatinine clearance
Item
serum creatinine =< 2.0 mg/dl or creatinine clearance (calculated) >= 60 ml/min
boolean
C0201976 (UMLS CUI [1])
C2711451 (UMLS CUI [2])
ALT/AST
Item
alt/ast =< 2.0 x upper limit of normal
boolean
C0201836 (UMLS CUI [1])
C0201899 (UMLS CUI [2])
Total bilirubin
Item
total bilirubin =< 1.5 x upper limit of normal
boolean
C0201913 (UMLS CUI [1])
Albumin
Item
albumin >= 3.0 g/dl
boolean
C0201838 (UMLS CUI [1])
ECOG
Item
subjects must have a performance status score (ecog scale) =< 2
boolean
C1520224 (UMLS CUI [1])
Active concurrent medical illness precluding protocol treatment
Item
subjects must have recovered from major infections and/or surgical procedures and, in the opinion of the investigator, not have a significant active concurrent medical illness precluding protocol treatment
boolean
C0525058 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
Contraceptive methods
Item
men and women of reproductive ability must agree to contraceptive use during the study and for 1month after ontak treatment is discontinued
boolean
C0700589 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Prior treatment with ontak (dab389 il-2) or dab486 il-2
Item
prior treatment with ontak (dab389 il-2) or dab486 il-2
boolean
C0722264 (UMLS CUI [1])
C0063713 (UMLS CUI [2])
Hypersensitivity to diphtheria toxin or il-2
Item
known history of hypersensitivity to diphtheria toxin or il-2
boolean
C0020517 (UMLS CUI [1,1])
C0012550 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0021756 (UMLS CUI [2,2])
Autoimmune disease
Item
active autoimmune disease
boolean
C0004364 (UMLS CUI [1])
Pulmonary disease
Item
known history of pulmonary disease except controlled asthma
boolean
C0024115 (UMLS CUI [1])
cardiovascular disease as defined by new york heart association class iii-iv categorization
Item
history of or pre-existing, cardiovascular disease as defined by new york heart association (nyha) class iii-iv categorization
boolean
C0007222 (UMLS CUI [1,1])
C1275491 (UMLS CUI [1,2])
Pregnant or breast-feeding
Item
pregnant or breast-feeding women
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial